Handa Pharmaceuticals, Inc. (TPEX:6620)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
96.30
+8.70 (9.93%)
Jul 30, 2026, 12:53 PM CST

Handa Pharmaceuticals Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
780.8749.77472.74726.89-40.01-247.67
Depreciation & Amortization
162.68163.8310.1612.1514.8216.49
Other Amortization
0.310.310.270.30.3618.67
Loss (Gain) From Sale of Assets
-12.84-12.840.19-4.610-0.02
Loss (Gain) on Equity Investments
-2.92-0.291.81-2.37--
Stock-Based Compensation
19.0916.3922.398.470.110.26
Other Operating Activities
-24.51-21.13-189.2351.87-5.55-13.62
Change in Accounts Receivable
-656.79-762.56207.08-226.18-140.5813.41
Change in Inventory
45.3539.22--10.11-
Change in Accounts Payable
54.247.046.578.345.1-8.26
Change in Other Net Operating Assets
-6.723.9-34.3893.51-55.9341.51
Operating Cash Flow
358.67243.63497.6668.36-211.57-179.24
Operating Cash Flow Growth
20.73%-51.04%-25.55%---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-35.18-16.92-7.77-0.94-0.64-5.58
Sale of Property, Plant & Equipment
--0-00.03
Cash Acquisitions
-155.9-155.9-819.63---
Divestitures
----10.97--
Sale (Purchase) of Intangibles
-0.17-0.17---0.12-1.57
Investment in Securities
-1,518-674.86431.12-1,65330.713.98
Other Investing Activities
---0.65--0.450.23
Investing Cash Flow
-1,709-847.84-396.92-1,66529.5-2.91

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--13.26-6.07-7.17-7.19-7.77
Total Debt Repaid
-13.19-13.26-6.07-7.17-7.19-7.77
Net Debt Issued (Repaid)
-13.19-13.26-6.07-7.17-7.19-7.77
Issuance of Common Stock
944.622,1023.121,313320.83170.68
Repurchase of Common Stock
-203.74-57.88-56.52---
Common Dividends Paid
-236.3-236.3-141.09---
Other Financing Activities
-3-3----
Financing Cash Flow
488.391,792-200.551,306313.65162.91

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
26.922.3930.2-8.34-28.972.44
Net Cash Flow
-834.841,210-69.67301.13102.6-16.81

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
323.49226.72489.84667.42-212.21-184.82
Free Cash Flow Growth
12.05%-53.72%-26.61%---
Free Cash Flow Margin
18.40%13.11%58.97%60.33%-107.35%-632.19%
Free Cash Flow Per Share
2.011.463.474.95-1.69-1.57
Levered Free Cash Flow
-287.3438.42450.86-224.91-74.36
Unlevered Free Cash Flow
-287.95438.73450.99-224.74-74.21

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1.11.040.490.220.280.23
Cash Income Tax Paid
191.02191.19197.467.782.420.45
Change in Working Capital
-563.93-652.4179.27-124.33-181.3146.66